Keynote Speakers
Bob Carter Professor and Chief of Neurosurgery, Massachusetts General Hospital, Harvard Medical School |
Jan Lötvall Professor Krefting Research Centre, University of Gothenburg, Chief Scientist, Codiak BioSciences; Founding President of ISEV |
Steve Soper Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas |
J. Carl Barrett Vice President, Translational Sciences Oncology, AstraZeneca |
Cheng-Ho Jimmy Lin Chief Scientific Officer, Oncology, Natera |
Tony Jun Huang William Bevan Distinguished Professor of Mechanical Engineering and Materials Science, Duke University |
|
Y. Peng Loh Chief and Senior Investigator, Section on Cellular Neurobiology, Eunice Kennedy Shriver National Institute of Child health and Human Development, National Institutes of Health (NIH) |
Jennifer Jones NIH Stadtman Investigator, Head of Transnational Nanobiology, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute |
Walter Koch Vice President, Roche Molecular Systems |
Shannon Stott Assistant Professor, Massachusetts General Hospital & Harvard Medical School |
George Calin Professor and The Alan M. Gewirtz Leukemia & Lymphoma Society Scholar, University of Texas MD Anderson Cancer Center |
Steven Pirie-Shepherd Director, Pfizer |
Balaji Panchapakesan Professor, Department of Mechanical Engineering, Worcester Polytechnic Institute (WPI) |
David Wong Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles |
Anindya Dutta Harry F. Byrd Professor and Chair of Biochemistry and Molecular Genetics and Professor of Pathology, University of Virginia School of Medicine |
Mike Makrigiorgos Professor of Radiation Oncology, Dana Farber Cancer Institute and Harvard Medical School |
Peter Quesenberry Professor of Medicine, The Warren Alpert Medical School of Brown University |
Lucia Languino Professor of Cancer Biology, Thomas Jefferson University |
Paul Robbins Professor, Department of Biochemistry, Molecular Biology, and Biophysics, and the Institute on the Biology of Aging and Metabolism, University of Minnesota Medical School |
Gyongyi Szabo Professor & Vice Chair for Research, Department of Medicine, University of Massachusetts Medical School |
Daniel Chiu A. Bruce Montgomery Professor of Chemistry, University of Washington |
OverviewSelect Biosciences Fifth Annual Circulating Biomarkers World Congress 2018 brings together the most up-to-date technologies and advances in this expanding and evolving field. Our coverage in this conference focuses on the various classes of circulating biomarkers and their emerging applications: - Extracellular Vesicles (EVs): Exosomes and Microvesicles
- Circulating Nucleic Acids: Circulating Cell-Free DNA, Circulating RNAs
- Circulating Cells in the Circulation (Circulating Tumor Cells and Cancer Stem Cells)
This conference features an international faculty of speakers from academia as well as industry addressing the following topic areas: - Technologies for Isolation and Characterization: Single Vesicle Analysis Approaches
- Role in Cancer and Various Disease Classes
- Biomarker Potential for Diagnostics Development
- Therapeutics Potential and Technology Advances in the EV Field
Registered delegates receive access to the co-located concurrent conference tracks, the co-located exhibit hall featuring companies from around the world providing tools/technologies, products and services addressing the circulating biomarkers field. QIAGEN Dinner Workshop to Registered Delegates Entitled "Cutting Edge NGS Workflows for Liquid Biopsy."Information and Local Registration Facilities for this Conference are also available in:
Japanese
|
Korean
|
Chinese (Simplified)
|
Chinese (Traditional)
Agenda and Information for:
|
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|